Hepione Therapeutics

Developer of immuno-therapeutics for opioid overdose and cancer

placeNew York City, New York, United States calendar_todayFounded 2019 language hepionetx.com

Innovation

4 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 88 times.

YearFilings
20233
20243
20253
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon